Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
PharmaVoice
JUNE 27, 2024
Neuroscience pipelines are reawakening as biotechs prove to the pharma giants that the field is still worth the investment.
Thu.Jun 27, 2024
307 
Blue Shield of California Launches New Way for Members to Interact with Health Info
MedCity News
JUNE 27, 2024
Blue Shield of California unveiled its new Member Health Record on Wednesday. It allows members to access their health information in one place within the insurer’s app or website. The post Blue Shield of California Launches New Way for Members to Interact with Health Info appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Billionaire Sackler family can't get legal immunity as part of Purdue bankruptcy deal, Supreme Court rules
Fierce Pharma
JUNE 27, 2024
Years of negotiations and legal proceedings surrounding a high-dollar opioid settlement for Purdue Pharma have reached a dead end at the U.S. Supreme Court. | Years of negotiations and legal proceedings surrounding a high-dollar opioid settlement for Purdue Pharma have reached a dead end at the U.S. Supreme Court.
What Do Experts Make of Risant Health’s Newest Acquisition?
MedCity News
JUNE 27, 2024
While it it’s too early to judge the success of Kaiser Permanente’s Risant Health, the company’s first two acquisitions show a commitment to adjoining organizations with a strong focus on population health — as well as a dedication to spreading Kaiser’s value-based care delivery models across the country. The post What Do Experts Make of Risant Health’s Newest Acquisition?
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma
Fierce Pharma
JUNE 27, 2024
With Regeneron’s treatment delayed, AbbVie is expanding its T-cell engager competition against Roche in blood cancer with a new FDA approval. | With Regeneron's treatment delayed, AbbVie is expanding its T-cell engager competition against Roche in blood cancer with a new FDA approval.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Fierce Pharma Asia—Daiichi, Merck's FDA rejection; Wegovy's expansion; Takeda CEO's hunt for China deals
Fierce Pharma
JUNE 27, 2024
The FDA rejected Daiichi Sankyo and Merck's HER3 antibody-drug conjugate. Novo Nordisk's weight loss star Wegovy secured approval in China. | The FDA rejected Daiichi Sankyo and Merck's HER3 antibody-drug conjugate. Novo Nordisk's weight-loss star Wegovy secured approval in China. After two large licensing deals, Takeda's CEO is open to more partnerships with Chinese biotechs.
The Impact of GI Disorders on Women’s Mental Health
MedCity News
JUNE 27, 2024
GI disorders are complex, disruptive, and immensely stressful, with physiological, psychological, and sociological implications. The post The Impact of GI Disorders on Women’s Mental Health appeared first on MedCity News.
Women with a common hormonal disorder have few good treatment options. Could GLP-1 drugs help?
PharmaVoice
JUNE 27, 2024
Obesity drugs like Wegovy are proving useful in many other diseases. Polycystic ovary syndrome, a chronic condition that can cause infertility, may be one.
Biden’s ‘March-In-Rights’ Proposal Undermines 40-Year-Old Policy, and Endangers Life-Saving Innovation
MedCity News
JUNE 27, 2024
It is crucial that we preserve the unique public-private partnership framework that drives innovation in our country by ensuring that the Bayh-Dole Act remains intact. The post Biden’s ‘March-In-Rights’ Proposal Undermines 40-Year-Old Policy, and Endangers Life-Saving Innovation appeared first on MedCity News.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Verona’s first-in-class COPD drug ‘could transform market’
pharmaphorum
JUNE 27, 2024
Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster.The first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, according to Verona.
McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement
Pharmaceutical Commerce
JUNE 27, 2024
The deal offers member pharmacies two pricing options, which will take effect Aug. 1.
FDA turns down MSD, Daiichi Sankyo HER3 ADC for lung cancer
pharmaphorum
JUNE 27, 2024
FDA rejects MSD, Daiichi Sankyo’s HER3-targeted ADC patritumab deruxtecan because of problems at a third-party manufacturer
Pharma Pulse 6/27/24: Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more
Pharmaceutical Commerce
JUNE 27, 2024
The latest news for pharma industry insiders.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Purdue’s bankruptcy plan in tatters as SCOTUS says no
pharmaphorum
JUNE 27, 2024
SCOTUS rejects bankruptcy deal that would settle opioid litigation against Purdue Pharma, but also protect the Sackler family from liability.
2seventy bio completes $40m haemophilia A program deal with Novo Nordisk
Pharmaceutical Technology
JUNE 27, 2024
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest its haemophilia A candidate to Novo Nordisk.
FDA reveals diversity action plan guide for clinical trials
pharmaphorum
JUNE 27, 2024
FDA reveals diversity action plan guide for clinical trials Phil.
FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market
Pharmaceutical Technology
JUNE 27, 2024
Data showed that Ohtuvayre significantly improved dyspnea compared to placebo in as little as six weeks and maintained this over 24 weeks.
10 Ways to Leverage Buyer Signals and Drive Revenue
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
England, Denmark back CSL’s haemophilia B gene therapy
pharmaphorum
JUNE 27, 2024
CSL Behring's gene therapy Hemgenix for haemophilia B has been backed for reimbursement in England and Denmark.
New collaboration aims to research early mutations in rare blood disorder
PharmaTimes
JUNE 27, 2024
Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK
Formation Bio secures $372m funds for AI-driven drug platform
Pharmaceutical Technology
JUNE 27, 2024
Formation Bio has secured $372m in Series D funding to bolster its drug pipeline and expand its AI-driven drug development platform.
UCL begins first UK deep brain stimulation study for children with rare epilepsy
PharmaTimes
JUNE 27, 2024
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Novo Nordisk’s ocedurenone Phase III flop costs company $816m
Pharmaceutical Technology
JUNE 27, 2024
NovoNordisk acquired the hypertension and kidney disease drug ocedurenone from KBP Biosciences in 2023 as part of a $1.3bn deal.
European Commission Approves Metastatic Colorectal Cancer Monotherapy
PharmaTech
JUNE 27, 2024
Fruzaqla was previously approved for use in patients with metastatic colorectal cancer in the US in November 2023.
Addressing Sales Enablement Pain Points with AI Solutions
Quantified
JUNE 27, 2024
Introduction In the ever shifting landscape of sales, enablement is crucial for business success. Sales enablement provides sales teams with the tools, resources, and information they need to engage buyers and close deals effectively. However, several pain points can hinder these efforts. Leveraging artificial intelligence (AI) can significantly mitigate these challenges, transforming sales enablement into a more efficient and effective process.
AI and stable funding environments are catalysts for biotech assets
Pharmaceutical Technology
JUNE 27, 2024
As the funding market evolves, there is greater emphasis on companies having commercial plans and using AI for drug discovery.
Signal-Based Selling: How to Leverage 4 Key Buying Signals
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
During Drug Shortages, There Are Resources so Pharmacists ‘Never Need to Ration Life-Saving Drugs’
Pharmacy Times
JUNE 27, 2024
Laura Bray, founder of Angels for Change, explains that addressing the 4 key economic causes to drug shortages can also help lead to effective solutions long-term.
Capturing the genAI boom for drug development
Pharmaceutical Technology
JUNE 27, 2024
Biotechs with AI-led drug pipelines appear to be enjoying higher investment attraction.
Expert: Having Conversations and Practicing Cultural Competency With LGBTQIA+ Patients
Pharmacy Times
JUNE 27, 2024
HOPA’s DEI Advisory Board Chair discusses how creating safe environments, using correct pronouns, and being willing to talk about patients’ mental and physical needs are significant when providing care to LGBTQIA+ patients.
Let's personalize your content